Previous Article | Next Article ![]()
Journal of Bacteriology, November 2003, p. 6719-6722, Vol. 185, No. 22
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.22.6719-6722.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Pulling
of Nascent SecM Controls the Duration of Its Translational Pause and Secretion-Responsive secA Regulation
Department of Molecular Biology and Biochemistry, Wesleyan University, Middletown, Connecticut 06459
Received 28 May 2003/ Accepted 27 August 2003
|
|
|---|
pulling
of nascent SecM is what regulates the duration of the secM translational pause, and thus secA expression levels, thereby providing direct support for this model. |
|
|---|
In Escherichia coli SecA level is regulated by the secretion needs of the cell such that secA derepression occurs when protein translocation is inhibited by either genetic or physiological means (e.g., in sec-defective mutants or in the presence of sodium azide, an inhibitor of SecA ATPase) (15, 17). This regulation was previously shown to (i) occur at the translational level; (ii) require an upstream gene, secM, which encodes a nonessential and rapidly degraded periplasmic protein; and (iii) utilize a repressor helix on secM-secA mRNA that regulates the accessibility of the secA Shine-Dalgarno sequence (10, 13, 18, 23). Recently the basis of this secretion-responsive regulation has come to light with the discovery of the existence of a natural translational pause at the end of secM that regulates formation of the repressor helix (13). The presence of a nonfunctional secM signal sequence, sec-defective alleles, or azide addition was all shown to lengthen the secM translational pause and result in secA derepression (13, 16). These observations lead to the proposal that the duration of the secM translational pause is controlled by the rate of secretion of nascent SecM protein through a coupling of its translation and secretion.
Additional studies have defined the secM translational pause site and have implicated this sequence and portions of the peptide exit channel of the ribosome in promoting the observed translational pause (12, 21). By contrast, the mechanism regulating the release of the secM translational pause remains less defined. Certainly in this regard, one attractive model is that the
pulling
action of the translocon and the use of SecA motor protein directly contribute to the dissociation of those regions of SecM that interact with the ribosomal peptide exit channel and are responsible for pausing. However, alternative models can certainly be entertained as well, such as the requirement for a trans-acting factor for pause release: e.g., a Sec protein or other factor whose activity would correlate with that of the Sec machinery.
In this study we have devised an experimental strategy to directly test the translocon pulling model of secA regulation by secM. We have engineered a stop transfer-membrane anchor sequence into secM prior to its translational pause site in order to stop the pulling action of the translocon distal to the anchor sequence. In this way we were able to uncouple secM translation from its secretion prior to the translocon reaching the pause site. In this communication we demonstrate that, if the secretion of SecM is prematurely terminated by its conversion into a stable integral membrane protein, then the normal release mechanism of secM translational pausing is circumvented, giving rise to constitutive secA derepression.
We made use of standard recombinant DNA methodology as described previously in order to construct the appropriate plasmid-bearing strains (20). A synthetic double-stranded oligonucleotide (Integrated DNA Technologies, Inc., Coralville, Iowa) was designed that encoded four tandem repeats of the hydrophobic peptide Leu-Ala-Leu-Val along with appropriate
sticky
ends for insertion into the BstBI site at codon 74 of secM (Fig. 1). Repeats of this peptide of 16 amino acid residues or longer have been employed previously to construct functional stop transfer-membrane anchor sequences (2). After treatment of the oligonucleotide with polynucleotide kinase and ATP and subsequent annealing, it was inserted into the BstBI site of pPhIF, which is a pBR322 derivative plasmid carrying the secM secA operon that also contains a secA-lacZ translational fusion (10). In order to enrich for plasmids that contained the oligonucleotide, the ligation mixture was treated with BstBI prior to transformation. A transformant that contained the plasmid with the membrane anchor sequence in the correct orientation, pPhIF-MA, was identified by DNA sequence analysis (University of Pennsylvania DNA sequence facility) and was selected for further study.
![]() View larger version (13K): [in a new window] |
FIG. 1. Creation of an artificial membrane anchor sequence in secM. The membrane anchor peptide sequence is shown along with a diagram of the secM secA operon that indicates the location of the atypical secM signal (SS) and translational pause sequences (codons 1 to 37 and 150 to 166, respectively) and the repressor helix that blocks the secA Shine-Dalgarno sequence (SD) (12, 22). The sites of insertion of the membrane anchor sequence within secM (BstBI at codon 74), the secM-phoA fusion joint (codon 157), and the secA-lacZ fusion joint (codon 67) are indicated. Only the 5' portion of secA is shown.
|
![]() View larger version (73K): [in a new window] |
FIG. 2. Effect of the secM membrane anchor sequence on secA regulation. CG155 (MC1000 recA) and CG29 [MC1000 secD1(Cs) phoR recA1 srl::Tn10] containing pPhIF or pPhIF-MA were grown in Luria broth containing 100 µg of ampicillin per ml at 39°C to mid-logarithmic phase when the cultures were shifted to 23°C for 4 h. ß-Galactosidase assays were performed in duplicate for each of two duplicate cultures as described previously (11). The average result is given with the error bar indicating the standard deviation.
|
In order to demonstrate that the observed difference in alkaline phosphatase activity was due to its cellular location, a subcellular fractionation experiment was performed on these strains. The results showed that the wild-type SecM-PhoA chimera was present in the soluble fraction, consistent with its predicted periplasmic location, while the SecM-PhoA chimera containing the membrane anchor was present in the membrane fraction, consistent with the presence of a functional membrane anchor sequence (Fig. 3). The membrane location of OmpA in both cases provided assurance of the fidelity of the fractionation methodology employed here. There was approximately a twofold difference in the steady-state levels of the two SecM-PhoA chimeras, indicating that the severe reduction in alkaline phosphatase activity of the chimera containing the membrane anchor was mostly due to its inactivity. The modest reduction in the steady-state level of this latter chimera was anticipated, given the inability of alkaline phosphatase on the cis side of the plasma membrane to acquire disulfide bonds and assemble properly, thus making it a target for proteolysis (3).
![]() View larger version (19K): [in a new window] |
FIG. 3. Subcellular location of the SecM-PhoA chimeras. CC118(pSS1) and CC118(pSS1-MA) were grown in Luria broth containing 100 µg of ampicillin per ml at 30°C to an optical density at 600 nm of 1.0, when cells were harvested by sedimentation at 7,000 x g for 5 min at 4°C. Cell pellets were resuspended in 0.02 volumes of TKMDP (25 mM TrisOAc [pH 7.5], 25 mM KCl, 1 mM MgOAc, 1 mM dithiothreitol, 0.5 mM EDTA, 0.5 mM phenylmethylsulfonyl fluoride, 100 µM leupeptin, 1 µM pepstatin, and 0.3 µM aprotinin) and broken by two passages at 8,000 lb/in2 in the French pressure cell. Unbroken cells were removed by two successive sedimentations at 13,000 x g for 10 min at 4°C, giving rise to the total cleared lysate (Total). Soluble (S150) and membrane (P150) fractions were obtained by sedimentation at 150,000 x g for 3 h at 4°C. The P150 fraction was resuspended in the original volume of TKMDP. A 28-µl [CC118(pSS1)] or 56-µl [CC118(pSS1-MA)] quantity of each fraction was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by Western blotting with alkaline phosphatase and OmpA antiserum and visualization with enhanced chemiluminescence as described by the manufacturer (Perkin-Elmer). The positions of the wild type (SecM-PhoA) and the SecM-PhoA chimera containing the membrane anchor (SecM-MA-PhoA) are given along with that of OmpA. Molecular mass markers are provided at the left.
|
Our results provide direct support for a model where translocon pulling of the nascent SecM polypeptide chain provides the necessary force to dislodge the paused SecM sequence within the ribosomal peptide exit channel. We assume that this action by SecA and the translocon could distort an unusual secondary or tertiary structure of the secM translational arrest sequence, FXXXXWIXXXXXGIRAGP (where X indicates any amino acid residue), which appears to interact with key residues of 23S rRNA and L22 protein at the narrowest constriction site of the peptide exit channel of the ribosome to effect the initial pause (12). Release of the secM translational pause followed by translational termination would allow reformation of the repressor helix on secM-secA mRNA and restore secA repression (12, 21). This model provides a simple explanation for how secA expression is tied to translocon function (i.e., secretion-responsive regulation). Presumably in the secretion-defective state the translocon would be largely unavailable to interact with nascent SecM signal peptide and unable to provide the necessary force during translocation to promote the release of the translationally arrested SecM complex. This defect would in turn prevent reformation of the secA repressor helix (since the arrested ribosome occupies sequences that comprise the 5' end of the repressor helix) (12, 21) and would promote secA derepression. Our results are not consistent with a whole class of trans-acting models, where a diffusible factor in the cytosol or the membrane would provide the linkage between translocon activity and the secM translational pause release step. Clearly additional studies of this intriguing system are warranted in order to decipher the details of this complex regulatory paradigm.
This work was supported by grant GM42033 from the National Institutes of Health to D.B.O.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»